Adolescent VALIANT subgroup data show pegcetacoplan cut proteinuria 75% vs placebo, supporting its expanded pediatric kidney indication.
|Articles|August 20, 2021
In case you missed it: August 16 to 20
It was a very busy week for the Contemporary Pediatrics team.
Advertisement
This week’s top articles included:
Nonprescription opioid use can significantly increase the risk of opioid overdose. What factors may lead teenagers to this high-risk behavior?
The Environmental Protection Agency (EPA) has said that they will reverse a 2017 decision that allowed the continued use of chloropyrifos on food.
The smell and taste of food are important to digestion and growth. Does providing preterm infants with the smell and taste of milk at feeding times lead to better weight and measurement results?
Just because the weather cools down in the Fall months, doesn't mean that respiratory allergies are done. Here's a look at some of the best respiratory allergy remedies.
Advertisement
Related to this article
The FDA approved Fayuvi (rebisufligene etisparvovec-hopf), a one-time AAV9 gene therapy, as the first treatment for pediatric MPS IIIA (Sanfilippo syndrome type A).
Aquestive resubmitted its NDA for dibutepinephrine sublingual film Anaphylm, citing new human factors and PK data addressing the FDA's CRL.
Melissa Wallach, MD, FAAP, discusses what pediatricians should know about updated screening, supplementation, and treatment recommendations for iron deficiency.
A Bifidobacterium-based synbiotic was well tolerated and increased colonization of administered strains in infants and toddlers.
Children with atopic dermatitis have higher ADHD risk, particularly with early, severe disease and sleep disturbance, a review found.
Baseline severity and clinical phenotype may help predict response to systemic therapy in children with alopecia areata.
Pediatricians can help teen athletes navigate sports supplements by prioritizing nutrition and identifying products to support, limit, or avoid.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Updated AAP guidance changes iron deficiency screening and treatment in children
2
FDA approves rebisufligene etisparvovec, first gene therapy for Sanfilippo syndrome type A
3
Pegcetacoplan reduces proteinuria, stabilizes kidney function in adolescents with C3G and IC-MPGN
4